drugset / Trial / NCT01022190

Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement

NCT01022190

Phase 4 Completed 42 enrolled Radboud University Medical Center
NaSingle-groupOpen-labelPrevention

Summary

The purpose of the study is to determine whether Arcoxia is effective in preventing heterotopic ossification after total hip arthroplasty.

Timeline

Start
2009-12
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoricoxib Small molecule 90 mg Oral

Indications